BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu Y, Teng L, Fu S, Wang G, Li Z, Ding C, Wang H, Bi L. Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers. BMC Cancer 2021;21:644. [PMID: 34053447 DOI: 10.1186/s12885-021-08318-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Cui R, Wang C, Li T, Hua J, Zhao T, Ren L, Wang Y, Li Y. Carboxypeptidase N1 is anticipated to be a synergy metrics for chemotherapy effectiveness and prognostic significance in invasive breast cancer. Cancer Cell Int 2021;21:571. [PMID: 34711246 DOI: 10.1186/s12935-021-02256-5] [Reference Citation Analysis]
2 Shi DL. RBM24 in the Post-Transcriptional Regulation of Cancer Progression: Anti-Tumor or Pro-Tumor Activity? Cancers (Basel) 2022;14:1843. [PMID: 35406615 DOI: 10.3390/cancers14071843] [Reference Citation Analysis]
3 Yan C, Liu Q, Jia R. Construction and Validation of a Prognostic Risk Model for Triple-Negative Breast Cancer Based on Autophagy-Related Genes. Front Oncol 2022;12:829045. [DOI: 10.3389/fonc.2022.829045] [Reference Citation Analysis]
4 Cirello V, Grassi ES, Pogliaghi G, Ghiandai V, Ermellino L, Muzza M, Gazzano G, Persani L, Colombo C, Fugazzola L. FAM83B is involved in thyroid cancer cell differentiation and migration. Sci Rep 2022;12:8608. [PMID: 35597845 DOI: 10.1038/s41598-022-12553-2] [Reference Citation Analysis]